To study whether CD33 expression might be a limiting factor for the anti-tumor activity of CC-96191, sublines of OCI-AML3 and KG-1 cells (both cell lines with low endogenous CD33 expression) were engineered to overexpress wild-type CD33 at increasing levels. Here, CD33 is linked to neoplasm.